# Encompass Health Corporation (EHC) Stock Analysis: A Growing Giant in Healthcare with 12.77% Upside Potential

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-ehc-stock-analysis-a-growing-giant-in-healthcare-with-12-77-upside-potential/4121212474
- Published: 2025-08-18T10:29:52+01:00
- Author: Madison Wilson

Encompass Health Corporation (NYSE: EHC) stands as a formidable player in the healthcare
sector, providing essential post-acute healthcare services across the United States
and Puerto Rico. With a market capitalization of $12.13 billion, Encompass Health
has solidified its position within the medical care facilities industry, demonstrating
robust growth and investor appeal.

Currently priced at $120.38, Encompass Health’s stock has shown resilience with 
a 52-week range between $88.60 and $122.63, indicating a strong recovery and steady
climb from its lower bounds. Despite a modest price change of 0.01%, the stock’s
trajectory aligns with its 50-day and 200-day moving averages of $116.23 and $105.87,
respectively, suggesting a positive upward trend.

A closer look at the valuation metrics reveals a forward P/E ratio of 20.83, which,
while higher than some industry peers, reflects investor confidence in the company’s
future earnings potential. Although some traditional metrics like the P/E ratio 
and PEG ratio are unavailable, the company’s strong performance metrics tell a compelling
story. With a revenue growth rate of 12.00% and an impressive return on equity of
24.72%, Encompass Health is capitalizing on its strategic focus in the rehabilitative
healthcare space.

Encompass Health’s financial health is further underscored by a free cash flow of
over $261 million, providing a solid foundation for operational expansion and shareholder
returns. The company’s dividend yield of 0.63%, coupled with a conservative payout
ratio of 13.26%, offers investors a stable income stream while retaining ample room
for reinvestment in growth initiatives.

Analyst ratings provide a resoundingly bullish outlook for Encompass Health, with
13 buy ratings and no hold or sell recommendations, indicating strong confidence
in the stock’s performance. The target price range of $125.00 to $145.00 suggests
a potential upside of approximately 12.77%, with an average target price of $135.75.

Technical indicators reinforce this optimistic view. The Relative Strength Index(
RSI) at 66.59 suggests that the stock is approaching overbought territory, a signal
of strong buying momentum. Meanwhile, the Moving Average Convergence Divergence (
MACD) at 1.41, with a signal line of 0.11, indicates a bullish trend continuation.

Encompass Health’s core operations and its strategic initiatives in inpatient rehabilitation
position it well within the healthcare sector. The company’s focus on specialized
rehabilitative treatments for conditions such as strokes and hip fractures, particularly
through the Medicare program, aligns with demographic trends favoring increased 
healthcare needs.

Founded in 1984 and headquartered in Birmingham, Alabama, Encompass Health has undergone
significant transformation, including a rebranding from HealthSouth Corporation 
in 2018. Its growth trajectory and strategic focus on offering high-quality rehabilitation
services continue to make it a compelling consideration for investors looking at
the healthcare sector.

For investors, Encompass Health represents a robust investment opportunity, characterized
by solid growth metrics, a steady dividend, and a positive outlook from the analyst
community. With its strategic positioning and financial performance, Encompass Health
is well-poised to deliver substantial returns, making it a stock worth watching 
in the healthcare landscape.

Share on: